| scholarly article | Q13442814 |
| P50 | author | Juan-Carlos Saiz | Q29382520 |
| Miguel A Martín-Acebes | Q37369364 | ||
| P2860 | cites work | Mosquitoes inoculate high doses of West Nile virus as they probe and feed on live hosts | Q24276401 |
| Persistence of virus-reactive serum immunoglobulin m antibody in confirmed west nile virus encephalitis cases | Q24570064 | ||
| Acute flaccid paralysis and West Nile virus infection | Q24594634 | ||
| Epidemiology and transmission dynamics of West Nile virus disease | Q24603195 | ||
| Virology, pathology, and clinical manifestations of West Nile virus disease | Q24603319 | ||
| Inhibition of interferon signaling by dengue virus | Q24630622 | ||
| Crow deaths as a sentinel surveillance system for West Nile virus in the northeastern United States, 1999 | Q24644771 | ||
| Clinical characteristics of the West Nile fever outbreak, Israel, 2000 | Q24644796 | ||
| Persistent neuroinvasive West Nile virus infection in an immunocompromised patient | Q40487274 | ||
| An inactivated West Nile virus vaccine for domestic geese-efficacy study and a summary of 4 years of field application | Q40503568 | ||
| Interaction of West Nile virus with alpha v beta 3 integrin mediates virus entry into cells | Q40505862 | ||
| Persistent West Nile virus infection in the golden hamster: studies on its mechanism and possible implications for other flavivirus infections | Q40506032 | ||
| Argasid ticks as possible vectors of West Nile virus in Israel | Q40511338 | ||
| Oral transmission of West Nile virus in a hamster model. | Q40512862 | ||
| Persistent shedding of West Nile virus in urine of experimentally infected hamsters | Q40512866 | ||
| Outcome of equids with clinical signs of West Nile virus infection and factors associated with death | Q40527556 | ||
| Enzyme-linked immunosorbent assays using recombinant envelope protein expressed in COS-1 and Drosophila S2 cells for detection of West Nile virus immunoglobulin M in serum or cerebrospinal fluid | Q40530275 | ||
| West Nile virus and other zoonotic viruses in Russia: examples of emerging-reemerging situations. | Q40534678 | ||
| Transmission of West Nile Virus through Blood Transfusion in the United States in 2002 | Q40550030 | ||
| Early season crow mortality as a sentinel for West Nile virus disease in humans, northeastern United States | Q40559517 | ||
| A recombinant envelope protein-based enzyme-linked immunosorbent assay for West Nile virus serodiagnosis | Q40562944 | ||
| The ecology and epidemiology of West Nile virus in Africa, Europe and Asia | Q40579990 | ||
| Mouse neuroinvasive phenotype of West Nile virus strains varies depending upon virus genotype | Q40581574 | ||
| Use of live and inactivated vaccines in the control of West Nile fever in domestic geese. | Q40590082 | ||
| Pathogenicity of West Nile virus in chickens | Q40614430 | ||
| An outbreak of West Nile fever among migrants in Kisangani, Democratic Republic of Congo. | Q40626312 | ||
| West Nile fever; the clinical features of the disease and the isolation of West Nile virus from the blood of nine human cases. | Q41037589 | ||
| Proteins C and NS4B of the flavivirus Kunjin translocate independently into the nucleus | Q41098886 | ||
| NS4A regulates the ATPase activity of the NS3 helicase: a novel cofactor role of the non-structural protein NS4A from West Nile virus | Q41147947 | ||
| West Nile virus differentially modulates the unfolded protein response to facilitate replication and immune evasion | Q41971863 | ||
| West Nile virus infection in crocodiles | Q42575452 | ||
| Serological evidence of West Nile virus, Usutu virus and Sindbis virus infection of birds in the UK. | Q42978092 | ||
| Subcellular localization and some biochemical properties of the flavivirus Kunjin nonstructural proteins NS2A and NS4A. | Q42988629 | ||
| Emergence of attenuated West Nile virus variants in Texas, 2003. | Q42988638 | ||
| Viral envelope protein glycosylation is a molecular determinant of the neuroinvasiveness of the New York strain of West Nile virus | Q42988971 | ||
| First isolation of mosquito-borne West Nile virus in the Czech Republic. | Q42990313 | ||
| Phylogenetic analysis of North American West Nile virus isolates, 2001-2004: evidence for the emergence of a dominant genotype | Q42994909 | ||
| First serological evidence of West Nile virus activity in horses in Serbia. | Q43035476 | ||
| West Nile virus strain Kunjin NS5 polymerase is a phosphoprotein localized at the cytoplasmic site of viral RNA synthesis | Q43036620 | ||
| Molecular characterization of the Japanese encephalitis serocomplex of the flavivirus genus | Q43046645 | ||
| High titer human immunoglobulin as a specific therapy against West Nile virus encephalitis. | Q44148976 | ||
| West Nile virus | Q56932479 | ||
| West Nile virus | Q64127859 | ||
| West Nile Virus Entry Requires Cholesterol-Rich Membrane Microdomains and Is Independent of v 3 Integrin | Q27486120 | ||
| The Two-component NS2B-NS3 Proteinase Represses DNA Unwinding Activity of the West Nile Virus NS3 Helicase | Q27486257 | ||
| Temperature, Viral Genetics, and the Transmission of West Nile Virus by Culex pipiens Mosquitoes | Q27486375 | ||
| West Nile Virus Nonstructural Protein 1 Inhibits TLR3 Signal Transduction | Q27486783 | ||
| Identification of specific histidines as pH sensors in flavivirus membrane fusion | Q27487066 | ||
| Morphologic and Molecular Characterization of New Cyclospora Species from Ethiopian Monkeys: C. cercopitheci sp.n., C. colobi sp.n., and C. papionis sp.n | Q27487726 | ||
| Outbreak of West Nile virus infection, Volgograd Region, Russia, 1999 | Q27487787 | ||
| West Nile Virus in OverwinteringCulexMosquitoes, New York City, 2000 | Q27487813 | ||
| West Nile Virus Infection in Birds and Mosquitoes, New York State, 2000 | Q27487817 | ||
| Genetic Variation in OAS1 Is a Risk Factor for Initial Infection with West Nile Virus in Man | Q27487937 | ||
| Closing the door on flaviviruses: Entry as a target for antiviral drug design | Q27487953 | ||
| The structural immunology of antibody protection against West Nile virus | Q27487955 | ||
| A recombinant West Nile virus envelope protein vaccine candidate produced in Spodoptera frugiperda expresSF+ cells | Q27487992 | ||
| A Therapeutic Antibody against West Nile Virus Neutralizes Infection by Blocking Fusion within Endosomes | Q27488367 | ||
| West Nile Virus Capsid Degradation of Claudin Proteins Disrupts Epithelial Barrier Function | Q27488431 | ||
| Changing patterns of West Nile virus transmission: altered vector competence and host susceptibility | Q27488733 | ||
| Virus and Host Determinants of West Nile Virus Pathogenesis | Q27488737 | ||
| A West Nile Virus DNA Vaccine Induces Neutralizing Antibody in Healthy Adults during a Phase 1 Clinical Trial | Q27488963 | ||
| Vector Competence of California Mosquitoes for West Nile virus | Q27489547 | ||
| West Nile virus envelope protein glycosylation is required for efficient viral transmission by Culex vectors | Q27489602 | ||
| Progress on the development of therapeutics against West Nile virus | Q27489893 | ||
| Extension of Flavivirus Protein C Differentially Affects Early RNA Synthesis and Growth in Mammalian and Arthropod Host Cells | Q27490326 | ||
| Capturing a Flavivirus Pre-Fusion Intermediate | Q27490389 | ||
| Protonation of Individual Histidine Residues Is Not Required for the pH-Dependent Entry of West Nile Virus: Evaluation of the "Histidine Switch" Hypothesis | Q27490468 | ||
| Persistent Infection with West Nile Virus Years after Initial Infection | Q27490502 | ||
| NS1' of Flaviviruses in the Japanese Encephalitis Virus Serogroup Is a Product of Ribosomal Frameshifting and Plays a Role in Viral Neuroinvasiveness | Q27490848 | ||
| The NS5 Protein of the Virulent West Nile Virus NY99 Strain Is a Potent Antagonist of Type I Interferon-Mediated JAK-STAT Signaling | Q27491054 | ||
| Glycosylation of the West Nile Virus Envelope Protein Increases In Vivo and In Vitro Viral Multiplication in Birds | Q27491308 | ||
| Crystal structure of the RNA polymerase domain of the West Nile virus non-structural protein 5 | Q27643756 | ||
| Crystal structure and activity of Kunjin virus NS3 helicase; protease and helicase domain assembly in the full length NS3 protein | Q27646900 | ||
| Neutralization of West Nile virus by cross-linking of its surface proteins with Fab fragments of the human monoclonal antibody CR4354 | Q27665151 | ||
| Introduction of West Nile virus in the Middle East by migrating white storks | Q24648207 | ||
| Rab 5 is required for the cellular entry of dengue and West Nile viruses | Q24683001 | ||
| Differential virulence of West Nile strains for American crows | Q24817166 | ||
| Genetic and fitness changes accompanying adaptation of an arbovirus to vertebrate and invertebrate cells | Q27469361 | ||
| Markers for trans-Golgi membranes and the intermediate compartment localize to induced membranes with distinct replication functions in flavivirus-infected cells | Q27469743 | ||
| West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays | Q27469785 | ||
| Inhibition of Alpha/Beta Interferon Signaling by the NS4B Protein of Flaviviruses | Q27469841 | ||
| Envelope protein glycosylation status influences mouse neuroinvasion phenotype of genetic lineage 1 West Nile virus strains | Q27469847 | ||
| Comparison of immunohistochemistry and virus isolation for diagnosis of west nile virus | Q27469980 | ||
| A nonsense mutation in the gene encoding 2'-5'-oligoadenylate synthetase/L1 isoform is associated with West Nile virus susceptibility in laboratory mice | Q27471916 | ||
| NS1 protein secretion during the acute phase of West Nile virus infection | Q27472703 | ||
| Detection of West Nile virus antigen in mosquitoes and avian tissues by a monoclonal antibody-based capture enzyme immunoassay | Q27472743 | ||
| West Nile Virus Discriminates between DC-SIGN and DC-SIGNR for Cellular Attachment and Infection | Q27472821 | ||
| A Single Amino Acid Substitution in the West Nile Virus Nonstructural Protein NS2A Disables Its Ability To Inhibit Alpha/Beta Interferon Induction and Attenuates Virus Virulence in Mice | Q27473041 | ||
| West Nile Virus 5'-Cap Structure Is Formed by Sequential Guanine N-7 and Ribose 2'-O Methylations by Nonstructural Protein 5 | Q27477465 | ||
| Pathogenesis of West Nile Virus Infection: a Balance between Virulence, Innate and Adaptive Immunity, and Viral Evasion | Q27477543 | ||
| Molecular and Functional Analyses of Kunjin Virus Infectious cDNA Clones Demonstrate the Essential Roles for NS2A in Virus Assembly and for a Nonconservative Residue in NS3 in RNA Replication | Q27477562 | ||
| Crystal Structure of West Nile Virus Envelope Glycoprotein Reveals Viral Surface Epitopes | Q27477610 | ||
| Crystal Structure of the West Nile Virus Envelope Glycoprotein | Q27477648 | ||
| Structure and Function of Flavivirus NS5 Methyltransferase | Q27478377 | ||
| Interaction of TIA-1/TIAR with West Nile and dengue virus products in infected cells interferes with stress granule formation and processing body assembly | Q27478442 | ||
| Structure of Immature West Nile Virus | Q27480359 | ||
| Cell proteins bind specifically to West Nile virus minus-strand 3' stem-loop RNA | Q27480733 | ||
| Ultrastructure of Kunjin virus-infected cells: colocalization of NS1 and NS3 with double-stranded RNA, and of NS2B with NS3, in virus-induced membrane structures | Q27480850 | ||
| West Nile virus infection in tree squirrels (Rodentia: Sciuridae) in California, 2004-2005 | Q27480966 | ||
| Interaction between the Cellular Protein eEF1A and the 3'-Terminal Stem-Loop of West Nile Virus Genomic RNA Facilitates Viral Minus-Strand RNA Synthesis | Q27481473 | ||
| West Nile Virus Infection Activates the Unfolded Protein Response, Leading to CHOP Induction and Apoptosis | Q27481502 | ||
| Differential Effects of Mutations in NS4B on West Nile Virus Replication and Inhibition of Interferon Signaling | Q27484997 | ||
| RNA chaperoning and intrinsic disorder in the core proteins of Flaviviridae | Q27485379 | ||
| Functional Analysis of Mosquito-Borne Flavivirus Conserved Sequence Elements within 3' Untranslated Region of West Nile Virus by Use of a Reporting Replicon That Differentiates between Viral Translation and RNA Replication | Q27485398 | ||
| A single positively selected West Nile viral mutation confers increased virogenesis in American crows | Q27485706 | ||
| Maturation of West Nile Virus Modulates Sensitivity to Antibody-Mediated Neutralization | Q27485890 | ||
| Role of Nonstructural Protein NS2A in Flavivirus Assembly | Q27485896 | ||
| West Nile virus and its emergence in the United States of America | Q34035068 | ||
| Complete genome sequences and phylogenetic analysis of West Nile virus strains isolated from the United States, Europe, and the Middle East | Q34136426 | ||
| West Nile virus lineage 2 as a cause of zoonotic neurological disease in humans and horses in southern Africa | Q34138893 | ||
| Migratory Birds and the Dispersal of Arboviruses in California | Q34160099 | ||
| Dengue virus nonstructural protein 3 redistributes fatty acid synthase to sites of viral replication and increases cellular fatty acid synthesis | Q34182803 | ||
| Transmission of West Nile virus from an organ donor to four transplant recipients | Q34201110 | ||
| West Nile virus antibodies in permanent resident and overwintering migrant birds in south-central Kansas | Q34296814 | ||
| Clinical characteristics and functional outcomes of West Nile Fever | Q34346420 | ||
| Alligators as West Nile virus amplifiers | Q34386796 | ||
| West Nile in the Mediterranean basin: 1950-2000. | Q34498793 | ||
| The ecology of West Nile virus in South Africa and the occurrence of outbreaks in humans | Q34498805 | ||
| West Nile virus transmission and ecology in birds | Q34498856 | ||
| Innate and Adaptive Immune Responses Determine Protection against Disseminated Infection by West Nile Encephalitis Virus | Q34542855 | ||
| West Nile virus in Mexico: evidence of widespread circulation since July 2002. | Q34555035 | ||
| The zoonotic flaviviruses of southern, south-eastern and eastern Asia, and Australasia: the potential for emergent viruses | Q34608396 | ||
| West Nile virus emergence and large-scale declines of North American bird populations | Q34629040 | ||
| The lake frog (Rana ridibunda)--one of the food hosts of blood-sucking mosquitoes in Tadzhikistan--a reservoir of the West Nile fever virus | Q34682266 | ||
| The emergence of West Nile virus in North America: ecology, epidemiology, and surveillance. | Q34705732 | ||
| The ecology and epidemiology of Kunjin virus | Q34705765 | ||
| Appraising the roles of CBLL1 and the ubiquitin/proteasome system for flavivirus entry and replication | Q34742933 | ||
| A West Nile virus DNA vaccine utilizing a modified promoter induces neutralizing antibody in younger and older healthy adults in a phase I clinical trial | Q34833926 | ||
| Immune responses to an attenuated West Nile virus NS4B-P38G mutant strain | Q35042669 | ||
| Molecular amplification assays for the detection of flaviviruses | Q35625010 | ||
| Common E protein determinants for attenuation of glycosaminoglycan-binding variants of Japanese encephalitis and West Nile viruses | Q35702608 | ||
| Structure and function of the 3' terminal six nucleotides of the west nile virus genome in viral replication | Q35702678 | ||
| New insights on the neuropathology of West Nile virus | Q35751389 | ||
| West Nile virus infection: a pediatric perspective | Q35762250 | ||
| Lineage 1 and 2 strains of encephalitic West Nile virus, central Europe | Q35805636 | ||
| West Nile virus infection of horses | Q35827499 | ||
| Phylogenetic analysis of West Nile virus isolates, Italy, 2008-2009 | Q35876706 | ||
| Evolution of new genotype of West Nile virus in North America | Q35876719 | ||
| Putative new lineage of west nile virus, Spain. | Q35877396 | ||
| Experimental infection of cats and dogs with West Nile virus | Q35879263 | ||
| Genome sequence and attenuating mutations in West Nile virus isolate from Mexico | Q35881143 | ||
| West Nile virus (WNV) transmission routes in the murine model: intrauterine, by breastfeeding and after cannibal ingestion | Q40359701 | ||
| Evaluation of an enzyme-linked immunosorbent assay for detection of West Nile virus infection based on a recombinant envelope protein produced in Trichoplusia ni larvae. | Q40365815 | ||
| Viral determinants in the NS3 helicase and 2K peptide that promote West Nile virus resistance to antiviral action of 2',5'-oligoadenylate synthetase 1b. | Q40367933 | ||
| West Nile virus transmission in 2008 in north-eastern Italy | Q40369859 | ||
| Prevalence of West Nile virus in migratory birds during spring and fall migration | Q40372045 | ||
| Declining mortality in American crow (Corvus brachyrhynchos) following natural West Nile virus infection | Q40376014 | ||
| Characterization of the functional requirements of West Nile virus membrane fusion | Q40377031 | ||
| Searching for West Nile virus (WNV) in Greece | Q40381166 | ||
| Specific interaction of capsid protein and importin-alpha/beta influences West Nile virus production | Q40381483 | ||
| Re-emergence of West Nile virus in Italy | Q40383685 | ||
| The continuous spread of West Nile virus (WNV): seroprevalence in asymptomatic horses | Q40394651 | ||
| Size matters: West Nile Virus neutralizing antibodies in resident and migratory birds in Spain | Q40417916 | ||
| Prevalence of West Nile virus neutralizing antibodies in Spain is related to the behavior of migratory birds | Q40422290 | ||
| Mutagenesis of the West Nile virus NS2B cofactor domain reveals two regions essential for protease activity | Q40424421 | ||
| Seroconversion in wild birds and local circulation of West Nile virus, Spain | Q40427623 | ||
| Prevalence of West Nile virus neutralizing antibodies in colonial aquatic birds in southern Spain. | Q40450082 | ||
| West Nile virus isolates from India: evidence for a distinct genetic lineage. | Q40456848 | ||
| Pregnancy increases the risk of mortality in West Nile virus-infected mice. | Q40459278 | ||
| Experimental infection of common garter snakes (Thamnophis sirtalis) with West Nile virus. | Q40461545 | ||
| Importance of vertical and horizontal transmission of West Nile virus by Culex pipiens in the Northeastern United States. | Q40465594 | ||
| Characteristics of an outbreak of West Nile virus encephalomyelitis in a previously uninfected population of horses. | Q40470071 | ||
| Prediction of human cases of West Nile virus by equine cases, Saskatchewan, Canada, 2003. | Q40475697 | ||
| Spread of equine West Nile virus encephalomyelitis during the 2002 Texas epidemic. | Q40477299 | ||
| A single amino acid substitution in the central portion of the West Nile virus NS4B protein confers a highly attenuated phenotype in mice. | Q40480964 | ||
| Effects of temperature on the transmission of west nile virus by Culex tarsalis (Diptera: Culicidae). | Q40481183 | ||
| West Nile virus infection among pregnant women in a northern Colorado community, 2003 to 2004. | Q40484950 | ||
| Detection of West Nile virus RNA from the louse fly Icosta americana (Diptera: Hippoboscidae). | Q40485103 | ||
| Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States | Q27860919 | ||
| 2'-O methylation of the viral mRNA cap evades host restriction by IFIT family members | Q28513232 | ||
| West Nile virus and the climate | Q28727528 | ||
| Phylogeny.fr: robust phylogenetic analysis for the non-specialist | Q29547666 | ||
| Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis | Q29615108 | ||
| Experimental infection of North American birds with the New York 1999 strain of West Nile virus | Q29616255 | ||
| RNA interference screen for human genes associated with West Nile virus infection | Q29616376 | ||
| Structure of West Nile Virus | Q29618173 | ||
| The molecular biology of West Nile Virus: a new invader of the western hemisphere | Q29620664 | ||
| West Nile encephalitis epidemic in southeastern Romania | Q29620822 | ||
| West Nile virus core protein; tetramer structure and ribbon formation. | Q30342184 | ||
| The endoplasmic reticulum provides the membrane platform for biogenesis of the flavivirus replication complex | Q30484619 | ||
| Kunjin virus: an Australian variant of West Nile? | Q30670534 | ||
| Stable expression of noncytopathic Kunjin replicons simulates both ultrastructural and biochemical characteristics observed during replication of Kunjin virus | Q31807116 | ||
| A single-amino acid substitution in West Nile virus 2K peptide between NS4A and NS4B confers resistance to lycorine, a flavivirus inhibitor | Q33555761 | ||
| OAS1 polymorphisms are associated with susceptibility to West Nile encephalitis in horses | Q33580157 | ||
| Persistence of West Nile virus in the central nervous system and periphery of mice | Q33586206 | ||
| Antagonism of the complement component C4 by flavivirus nonstructural protein NS1. | Q33795001 | ||
| Safety and pharmacokinetics of single intravenous dose of MGAWN1, a novel monoclonal antibody to West Nile virus. | Q33876476 | ||
| Epidemiology of west nile in europe and in the mediterranean basin | Q33886961 | ||
| First serological evidence of West Nile virus in human rural populations of Gabon | Q33951787 | ||
| Isolation of West Nile virus in Israel | Q33968689 | ||
| West Nile virus: an overview of its spread in Europe and the Mediterranean basin in contrast to its spread in the Americas | Q33976242 | ||
| West Nile virus replication requires fatty acid synthesis but is independent on phosphatidylinositol-4-phosphate lipids | Q34031714 | ||
| Experimental infection of horses with West Nile virus | Q36086285 | ||
| Recent advances in the molecular biology of west nile virus | Q36352339 | ||
| Immunopathology of flavivirus infections | Q36673924 | ||
| West Nile virus: recent trends in diagnosis and vaccine development | Q36733137 | ||
| The long-term outcomes of human West Nile virus infection | Q36827974 | ||
| Transmission dynamics and changing epidemiology of West Nile virus | Q37112957 | ||
| Flavivirus methyltransferase: a novel antiviral target | Q37197519 | ||
| The flavivirus polymerase as a target for drug discovery. | Q37210620 | ||
| West Nile Virus NS2B/NS3 protease as an antiviral target | Q37320270 | ||
| Infectious entry of West Nile virus occurs through a clathrin-mediated endocytic pathway | Q37511523 | ||
| Vaccines and immunotherapeutics for the prevention and treatment of infections with West Nile virus | Q37842337 | ||
| Study on West Nile virus persistence in monkeys | Q38892318 | ||
| Limited evolution of West Nile virus has occurred during its southwesterly spread in the United States | Q38898384 | ||
| Impact of climate variation on mosquito abundance in California | Q39103459 | ||
| West Nile virus-induced bax-dependent apoptosis | Q39339987 | ||
| Drought-induced amplification and epidemic transmission of West Nile virus in southern Florida | Q39450831 | ||
| Recovery and identification of West Nile virus from a hawk in winter. | Q39460317 | ||
| A West Nile virus mutant with increased resistance to acid-induced inactivation | Q39608702 | ||
| Dephosphorylation of West Nile virus capsid protein enhances the processes of nucleocapsid assembly. | Q39638317 | ||
| West Nile virus capsid protein interaction with importin and HDM2 protein is regulated by protein kinase C-mediated phosphorylation | Q39711100 | ||
| Inhibition of enveloped virus infection of cultured cells by valproic acid | Q39813573 | ||
| Tyrosine 78 of premembrane protein is essential for assembly of West Nile virus | Q39876661 | ||
| West Nile virus genome amplification requires the functional activities of the proteasome | Q39902786 | ||
| Terminal structures of West Nile virus genomic RNA and their interactions with viral NS5 protein | Q39938749 | ||
| West Nile virus genome cyclization and RNA replication require two pairs of long-distance RNA interactions | Q40015473 | ||
| Cholesterol manipulation by West Nile virus perturbs the cellular immune response | Q40051201 | ||
| West Nile virus-induced cytoplasmic membrane structures provide partial protection against the interferon-induced antiviral MxA protein | Q40065552 | ||
| Interactions between the West Nile virus capsid protein and the host cell-encoded phosphatase inhibitor, I2PP2A. | Q40080517 | ||
| West Nile virus capsid protein induces p53-mediated apoptosis via the sequestration of HDM2 to the nucleolus. | Q40094517 | ||
| Mutations in West Nile virus nonstructural proteins that facilitate replicon persistence in vitro attenuate virus replication in vitro and in vivo | Q40154937 | ||
| The non-structural protein 4A of dengue virus is an integral membrane protein inducing membrane alterations in a 2K-regulated manner | Q40174839 | ||
| Jab1 mediates cytoplasmic localization and degradation of West Nile virus capsid protein. | Q40249081 | ||
| Hsp70 functions as a negative regulator of West Nile virus capsid protein through direct interaction | Q40253620 | ||
| Analysis of the endocytic pathway mediating the infectious entry of mosquito-borne flavivirus West Nile into Aedes albopictus mosquito (C6/36) cells | Q40313884 | ||
| Recombinant West Nile virus envelope protein E and domain III expressed in insect larvae protects mice against West Nile disease | Q40338129 | ||
| Phylogeography of West Nile virus: from the cradle of evolution in Africa to Eurasia, Australia, and the Americas | Q40340633 | ||
| A balance between circular and linear forms of the dengue virus genome is crucial for viral replication | Q40345189 | ||
| Ongoing outbreak of West Nile virus infections in humans in Greece, July-August 2010. | Q40349760 | ||
| P433 | issue | 2 | |
| P921 | main subject | West Nile virus | Q158856 |
| emerging pathogen | Q108429945 | ||
| P1104 | number of pages | 20 | |
| P304 | page(s) | 51-70 | |
| P577 | publication date | 2012-04-01 | |
| P1433 | published in | World journal of virology | Q27725044 |
| P1476 | title | West Nile virus: A re-emerging pathogen revisited | |
| P478 | volume | 1 |
| Q38836534 | A Brief Review of West Nile Virus Biology |
| Q64933402 | A Recombinant Subviral Particle-Based Vaccine Protects Magpie (Pica pica) Against West Nile Virus Infection. |
| Q28534723 | A single amino acid substitution in the core protein of West Nile virus increases resistance to acidotropic compounds |
| Q41510067 | Amino acid substitutions in the non-structural proteins 4A or 4B modulate the induction of autophagy in West Nile virus infected cells independently of the activation of the unfolded protein response |
| Q38157380 | Antiviral Properties of the Natural Polyphenols Delphinidin and Epigallocatechin Gallate against the Flaviviruses West Nile Virus, Zika Virus, and Dengue Virus |
| Q30145610 | Antiviral activity of nordihydroguaiaretic acid and its derivative tetra-O-methyl nordihydroguaiaretic acid against West Nile virus and Zika virus |
| Q40121936 | Chronic West Nile virus infection in kea (Nestor notabilis). |
| Q30196670 | Culex pipiens and Stegomyia albopicta (= Aedes albopictus) populations as vectors for lineage 1 and 2 West Nile virus in Europe. |
| Q90233695 | Current Progress of Avian Vaccines Against West Nile Virus |
| Q54558540 | Direct Activation of Adenosine Monophosphate-Activated Protein Kinase (AMPK) by PF-06409577 Inhibits Flavivirus Infection through Modification of Host-Cell Lipid Metabolism. |
| Q28067084 | Diversity of susceptible hosts in canine distemper virus infection: a systematic review and data synthesis |
| Q38605122 | Extinction of West Nile virus by Favipiravir through lethal mutagenesis. |
| Q35206866 | High seroprevelance of West Nile virus antibodies observed in horses from southwestern Nigeria |
| Q52596435 | High susceptibility of magpie (Pica pica) to experimental infection with lineage 1 and 2 West Nile virus. |
| Q36617464 | Host sphingomyelin increases West Nile virus infection in vivo |
| Q35214362 | Identifying the environmental conditions favouring West Nile Virus outbreaks in Europe |
| Q24273361 | Inhibition of West Nile Virus Multiplication in Cell Culture by Anti-Parkinsonian Drugs |
| Q41366671 | Limited susceptibility of mice to Usutu virus (USUV) infection and induction of flavivirus cross-protective immunity. |
| Q27025556 | Mechanism of West Nile virus neuroinvasion: a critical appraisal |
| Q38824741 | Modification of the Host Cell Lipid Metabolism Induced by Hypolipidemic Drugs Targeting the Acetyl Coenzyme A Carboxylase Impairs West Nile Virus Replication |
| Q112076508 | Mosquito-borne arboviruses in Uganda: history, transmission and burden |
| Q27927995 | Neurological manifestations of Zika virus infection |
| Q51336673 | Pharmacological Inhibition of Protein Kinase C Reduces West Nile Virus Replication. |
| Q39836648 | Prevalence of neutralizing antibodies against West Nile virus (WNV) in monkeys (Ateles geoffroyi and Alouatta pigra) and crocodiles (Crocodylus acutus and C. acutus-C. moreletti hybrids) in Mexico. |
| Q34482403 | Protection against West Nile virus infection in mice after inoculation with type I interferon-inducing RNA transcripts. |
| Q34208783 | Protection of a single dose west nile virus recombinant subviral particle vaccine against lineage 1 or 2 strains and analysis of the cross-reactivity with Usutu virus |
| Q40238422 | Protection of red-legged partridges (Alectoris rufa) against West Nile virus (WNV) infection after immunization with WNV recombinant envelope protein E (rE). |
| Q41255718 | Reconciling West Nile virus with the autophagic pathway |
| Q63248436 | Targeting host metabolism by inhibition of acetyl-Coenzyme A carboxylase reduces flavivirus infection in mouse models |
| Q30588461 | The composition of West Nile virus lipid envelope unveils a role of sphingolipid metabolism in flavivirus biogenesis. |
| Q93078517 | Therapeutic Advances Against ZIKV: A Quick Response, a Long Way to Go |
| Q56476829 | Tick-Borne Flaviviruses and the Type I Interferon Response |
| Q38535066 | West Nile virus infection in cats: ABCD guidelines on prevention and management |
| Q40167629 | West Nile virus serosurveillance in pigs, wild boars, and roe deer in Serbia |
| Q40037723 | Zika Virus: What Have We Learnt Since the Start of the Recent Epidemic? |
| Q24261118 | Zika Virus: the Latest Newcomer |
| Q41918368 | Zika virus infection confers protection against West Nile virus challenge in mice |
Search more.